Navigation Links
One third of stunting and a quarter of deaths among under 3s in poor countries could be prevented
Date:1/16/2008

If existing maternal and child nutrition interventions were implemented in poor countries, cases of stunting among under 3s could be reduced by a third, and deaths by up to a quarter, according to new research being published today.

Professor Simon Cousens, of the London School of Hygiene & Tropical Medicine, is one of the authors of a paper which appears as part of the Lancet Maternal and Child Undernutrition Series, which is being launched this week. Professor Cousens, along with four other series authors, is presenting his findings at a press event at the Science Media Centre.

178 million children under five are stunted, and most of these live in Sub-Saharan Africa and south-central Asia. 160 million stunted children (90%) live in just 36 countries, and make up 46% of the 348 million children in those countries. In addition, 19 million children are affected by severe acute malnutrition.

Historical evidence of improvements in nutrition in developed countries has shown that stature, living standards, reduced disease exposure and education are linked, and that almost all stunting is avoidable. Stunting is difficult to reverse after the age of three, so it is important to focus on interventions in pregnancy and in young children, especially those aged under two. In the past most nutrition programme reports and assessments have focused on weight gain rather than linear growth, and linear-growth retardation has been viewed as difficult to change. However, in the short term, about one third of stunting could be averted with existing interventions, say the authors. These include strategies to promote improved complementary feeding, micronutrient interventions, and interventions aimed at reducing the burden of disease.

In addition to reducing stunting, nutrition interventions, including breastfeeding promotion, could prevent about one quarter of child deaths in the 36 countries in which 90% of the worlds stunted children live, whil
'/>"/>

Contact: Gemma Howe
gemma.howe@lshtm.ac.uk
020-792-72802
London School of Hygiene & Tropical Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call
2. American Life League Announces Third Training and Activism Weekend
3. ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding
4. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter Earnings
5. The Ensign Group, Inc. Reports Third Quarter 2007 Earnings
6. Par Pharmaceutical Reports Third-Quarter 2007 Results
7. AHIP Releases Individual Market Guarantee Access Proposal, Announces Support for Third Party Review of Rescission Decisions
8. China Sky One Medical Completes Previously Announced Amendments to Form 10QSB for the Second and Third Quarters of 2006
9. AIRLIFE Denver Spreads its Wings with Third Helicopter
10. Surgical Care Affiliates Announces Investor Conference Call to Discuss Third Quarter 2007 Results
11. The Ensign Group, Inc. to Announce Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...TON-SALEM, N.C. Free drug samples provided to phy... be costing uninsured patients more in the long ru...e Forest University Baptist Medical Center and col... prescribing habits of more than 70 physicians in ... in the months immediately before and after the cl...
(Date:9/4/2008)...PAIGN, Ill. Many older Americans may be shortchan...urity too soon, according to a University of Illin...program for nearly two decades. , More than thre...l Security checks for life by claiming benefits ea...erstood the program,s options and consequences, la...
(Date:9/4/2008)...als want stronger labeling about fungal infection ...ews) -- Federal health authorities have asked the ...e drugs to bolster safety warnings on the risk of ...he drugs, Humira, Cimzia, Enbrel and Remicade, bel...sis factor alpha blockers (TNF-alpha blockers), wh...
(Date:9/4/2008)...CIFIC PALISADES, Calif., Sept. 4 /PRNewswire/ -- M...cognized authority in the field of weight,control ...Who in,California," "Who,s Who in The West," "Who,...s Who in Medicine and Health Care" and other honor...s expertise to exposing the,inaccurate, misleading...
Breaking Medicine News(10 mins):Health News:Free drug samples may end up costing uninsured more 2Health News:Free drug samples may end up costing uninsured more 3Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 3Health News:Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss 'No Diet, No Stuff' Method. Hates Diets, Loves to Have People Help Themselves 2
...formula Gentlease is being recalled from the marke... of metal particles in some cans. // So this brand... Gentlease powdered infant formula, Mead Johnson N...itiated the voluntary recall of 24-ounce cans with...
... in France are on tenterhooks, preventing the spre... exist on a turkey farm in the Eastern past of Fra...witnessed the illness of many turkeys, was just 20...ks were among the first to get the bird flu virus ...
...us disease expert has warned against indiscriminat...ibiotics Australians use ,are prescribed inappropr... Australian Society for Antimicrobials annual scie...robiologist John Turnidge, of the Adelaide Women's...
...e, a potential post-operative complication followi... prevented by provision of xenon gas, a new study ...l clinical trial can be found in Anesthesiology jo...dministered xenon gas safely to a group of 12 pati...
Other Medicine News:
(Date:9/4/2008)... -Data Published in ,The Lancet, and Presented ...re/ -- Results from a new international,study, the... 1 g/d dose of,omega-3 acid ethyl esters reduced a...diovascular reasons in patients with chronic heart...k,s online version of ,The,Lancet, and were presen...
(Date:9/4/2008)... ZURICH, Switzerland, September 4 /- ...Ia trial to assess the safety and tolerability,of ... severe pulmonary,infection in cystic fibrosis pat...herapeutic agent to be delivered directly to the s...compare the effects of two,different doses of the ...
(Date:9/4/2008)...Data Announcements Remain on Schedule with Two Abs...inical Data Release in November 2008, BRIDGEWATER...ticals,Inc., a specialty pharmaceutical company f...bolic disease, today announced the appointment of,... directors., Peter Garrambone,s career includes m...
(Date:9/3/2008)...he American College of Rheumatology Research and E...ields Significant Advances in Detecting, ..., Sept. 3 /- For the first time durin...rheumatoid arthritis, the,American College of Rheu...asing new information acquired from research funde...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3The next generation 3A nanomagnets could replace semiconductors 300 1The next generation 3A nanomagnets could replace semiconductors 300 2The next generation 3A nanomagnets could replace semiconductors 300 3Stevens to host Nanoscience Nanotechnology 26amp 3B Corrosion symposium Nov 13 298 1Novel 3 D cell culture model shows selective tumour uptake of nanoparticles 361 1Novel 3 D cell culture model shows selective tumour uptake of nanoparticles 361 2Melanoma drug revs immune cells but cancer cells ignore it 358 1Melanoma drug revs immune cells but cancer cells ignore it 358 2
...Conn., April 19, 2007 /PRNewswire-FirstCall/ --,Cu...ay that,preliminary interim clinical data on intra...(HDAC) inhibitor being investigated,for the treatm...,upcoming major medical meetings. , One oral and o...,results with belinostat will be made at the 2007 ...
...Mass.--(BUSINESS WIRE)--Apr 18, 2007 - Critical,Th...at new,preclinical research demonstrating a role i... Mobility Group Box-1 protein (HMGB1), a,pro-infla...will be,published in the May 2007 issue of Nature ...1 is part of DNA complexes that,can stimulate immu...
Other Medicine Technology:CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 2CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 3CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 4CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 5Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 2Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 3Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 4Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 5
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: